Protalix BioTherapeutics CEO David Aviezer To Retire
(dpa-AFX International Compact Via Acquire Media NewsEdge) JERUSALEM (dpa-AFX) - Protalix BioTherapeutics Inc. (PLX) announced that David Aviezer has decided to retire after almost 12 years from his role as the Company's President and Chief Executive Officer. He will retire this year upon the completion of a process to nominate his successor.
In the meantime, Aviezer will continue serving as President and Chief Executive Officer and remains a member of the Board of Directors.
The company's Board will appoint a committee to select a new Chief Executive Officer.
Copyright RTT News/dpa-AFX
[ Back To Technology News's Homepage ]